[{"id":"c2798bea-d53d-468b-9a48-fa6038ef935d","acronym":"","url":"https://clinicaltrials.gov/study/NCT03326947","created_at":"2022-05-26T23:55:05.469Z","updated_at":"2024-07-02T16:35:18.484Z","phase":"Phase 2","brief_title":"Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC","source_id_and_acronym":"NCT03326947","lead_sponsor":"Shanghai Jiao Tong University School of Medicine","biomarkers":" STMN1","pipe":"","alterations":" ","tags":["STMN1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • docetaxel • 5-fluorouracil"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 01/01/2018","start_date":" 01/01/2018","primary_txt":" Primary completion: 01/01/2026","primary_completion_date":" 01/01/2026","study_txt":" Completion: 01/01/2027","study_completion_date":" 01/01/2027","last_update_posted":"2024-02-20"},{"id":"eb1e4a0b-e825-4b2b-a74f-b5f287513f5e","acronym":"STMN1-LP","url":"https://clinicaltrials.gov/study/NCT01505153","created_at":"2022-05-26T23:55:03.008Z","updated_at":"2024-07-02T16:37:13.742Z","phase":"Phase 1","brief_title":"Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer","source_id_and_acronym":"NCT01505153 - STMN1-LP","lead_sponsor":"Gradalis, Inc.","biomarkers":" STMN1","pipe":"","alterations":" ","tags":["STMN1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e pbi-shRNA STMN1 LP"],"overall_status":"Completed","enrollment":" Enrollment 20","initiation":"Initiation: 02/01/2012","start_date":" 02/01/2012","primary_txt":" Primary completion: 03/01/2017","primary_completion_date":" 03/01/2017","study_txt":" Completion: 04/13/2017","study_completion_date":" 04/13/2017","last_update_posted":"2018-02-22"}]